AMENDMENT TO EXPENSE LIMITATION AGREEMENTS (the “Agreements”) Between Each of the T. Rowe Price Funds (collectively “the Funds”) set forth on Schedule A hereto, severally and not jointly andExpense Limitation Agreement • April 28th, 2020 • T. Rowe Price Quantitative Management Funds, Inc.
This is an Amendment (the “Amendment”), effective as of October 1, 2019, to each of the Expense Limitation Agreements (each an “Agreement” and collectively the “Agreements”) dated October 19, 2015, by and between T. Rowe Price Associates, Inc. (the “Manager”), a corporation organized and existing under the laws of the State of Maryland, and T. Rowe Price Quantitative Management Funds, Inc. (the “Corporation”), a corporation organized and existing under the laws of the State of Maryland, on behalf of each of the following funds, separately and not jointly: T. Rowe Price QM Global Equity Fund, T. Rowe Price QM U.S. Small & Mid-Cap Core Equity Fund, and T. Rowe Price QM U.S. Value Equity Fund (each a “Fund” and collectively the “Funds”) with respect to each of the Fund’s Investor Class.
